Drugs / Zr-Df-IAB22M2C
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04180215 | Dec 2019 → Jan 2025 | human papillomavirus-related squamous cell carcinoma | Hookipa Biotech GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zr-Df-IAB22M2C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04180215 ↗ |
| Modality | Diagnostic / imaging agent | “CD8 PET Tracer (Zr-Df-IAB22M2C)” NCT04180215 ↗ |